BRPI1006666A2 - " composição farmacêutica e uso de uma composição farmacêutica" - Google Patents

" composição farmacêutica e uso de uma composição farmacêutica"

Info

Publication number
BRPI1006666A2
BRPI1006666A2 BRPI1006666A BRPI1006666A BRPI1006666A2 BR PI1006666 A2 BRPI1006666 A2 BR PI1006666A2 BR PI1006666 A BRPI1006666 A BR PI1006666A BR PI1006666 A BRPI1006666 A BR PI1006666A BR PI1006666 A2 BRPI1006666 A2 BR PI1006666A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
BRPI1006666A
Other languages
English (en)
Portuguese (pt)
Inventor
Claire Mallard
Nathalie Willcox
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Publication of BRPI1006666A2 publication Critical patent/BRPI1006666A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI1006666A 2009-03-06 2010-03-05 " composição farmacêutica e uso de uma composição farmacêutica" BRPI1006666A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20251609P 2009-03-06 2009-03-06
FR0951416A FR2942716B1 (fr) 2009-03-06 2009-03-06 Methode de solubilisation d'agent antifongique et compositions a haute concentration en agent antifongique applicables sur l'ongle
PCT/EP2010/052817 WO2010100252A1 (en) 2009-03-06 2010-03-05 Method of dissolving antifungal agent, and compositions with a high concentration of antifungal agent, suitable for application to the nail

Publications (1)

Publication Number Publication Date
BRPI1006666A2 true BRPI1006666A2 (pt) 2016-04-19

Family

ID=41056884

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006666A BRPI1006666A2 (pt) 2009-03-06 2010-03-05 " composição farmacêutica e uso de uma composição farmacêutica"

Country Status (11)

Country Link
EP (1) EP2403476A1 (zh)
JP (1) JP2012519669A (zh)
KR (1) KR20110121702A (zh)
CN (1) CN102341092A (zh)
AU (1) AU2010220266A1 (zh)
BR (1) BRPI1006666A2 (zh)
CA (1) CA2753638A1 (zh)
FR (1) FR2942716B1 (zh)
MX (1) MX2011009093A (zh)
RU (1) RU2011140574A (zh)
WO (1) WO2010100252A1 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
KR101647545B1 (ko) * 2011-02-11 2016-08-10 모베르그 파르마 아베 신규 항진균 조성물
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
MY179756A (en) 2013-10-03 2020-11-12 Dow Pharmaceutical Sciences Stabilized efinaconazole formulations
JP6611014B2 (ja) 2013-11-22 2019-11-27 ボシュ ヘルス アイルランド リミテッド 抗感染方法、抗感染組成物、および抗感染装置
PT3209319T (pt) * 2014-10-21 2021-09-24 Hexima Ltd Um método de tratamento

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20080261986A1 (en) * 2007-03-30 2008-10-23 Friden Phillip M Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug

Also Published As

Publication number Publication date
FR2942716A1 (fr) 2010-09-10
WO2010100252A1 (en) 2010-09-10
CN102341092A (zh) 2012-02-01
EP2403476A1 (en) 2012-01-11
CA2753638A1 (en) 2010-09-10
MX2011009093A (es) 2011-09-27
JP2012519669A (ja) 2012-08-30
AU2010220266A1 (en) 2011-09-08
FR2942716B1 (fr) 2011-04-15
RU2011140574A (ru) 2013-04-20
KR20110121702A (ko) 2011-11-08

Similar Documents

Publication Publication Date Title
BRPI1011876A2 (pt) "composição farmacêutica estável e métodos de uso da mesma"
BRPI1006666A2 (pt) " composição farmacêutica e uso de uma composição farmacêutica"
BRPI0905680A2 (pt) "composição farmacêutica de uma composição farmacêutica"
BRPI0917315A2 (pt) anticorpo, composicao farmaceutico, e, uso de uma composicao farmaceutica
BRPI0821165A2 (pt) Uso de uma composição
BRPI1014316A2 (pt) composição, e, uso de uma composição
BR112012002331A2 (pt) composição antiviral, composição farmacêutica e uso de quantidade efetiva de composição farmacêutica
BRPI0813770A2 (pt) Composição, e, uso de uma composição
BRPI1008793A2 (pt) composto, uso de um composto, e, composição farmacêutica
BRPI1016219A2 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BR112012013148A2 (pt) formulação farmacêutica e uso
BR112012015392A2 (pt) "composto e uso cosmético de um composto"
BRPI1005931A2 (pt) associação de compostos, uso de uma associação, produto em forma de kit, uso de um produto e composição farmacêutica
BRPI0917001A2 (pt) composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
BRPI0813017A2 (pt) " formulação líquida e uso de uma formulação líquida "
BRPI0914793A2 (pt) Composição, e, uso de uma composição
BRPI1008039A2 (pt) composto, mistura, composição farmacêutica, e, uso de um coposto, de uma mistura ou de uma composição farmacêutica
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
BR112012014028A2 (pt) uso de uma composição
BRPI0906253A2 (pt) Composição de dentifrício, e, uso de uma composição
BRPI0920355A2 (pt) composições farmacêuticas tópicas estáveis de ozenoxacina e uso de ozenoxacina
BRPI1012250A2 (pt) composição lubrificante, e, uso de uma composição lubrificante

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A E 6A ANUIDADES

B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]